Journal Club
Tuesday, December 16, 2025 | 12:00 PM – 1:00 PM ET
Hosted by the American Society of Nephrology
Featured article: Xenotransplantation of a Porcine Kidney for End-Stage Kidney Disease
NEJM: Published February 7, 2025 | N Engl J Med 2025;392:1933-1940 | DOI: 10.1056/NEJMoa241274
Volume 392 Number 19 | Copyright © 2025

In this article:
Xenotransplantation offers a potential solution to the organ shortage crisis. A 62-year-old hemodialysis-dependent man with long-standing diabetes, advanced vasculopathy, and marked dialysis-access challenges received a gene-edited porcine kidney with 69 genomic edits, including deletion of three glycan antigens, inactivation of porcine endogenous retroviruses, and insertion of seven human transgenes. The xenograft functioned immediately. The patient's creatinine levels decreased promptly and progressively, and dialysis was no longer needed. After a T-cell–mediated rejection episode on day 8, intensified immunosuppression reversed rejection. Despite sustained kidney function, the patient died from unexpected, sudden cardiac causes on day 52; autopsy revealed severe coronary artery disease and ventricular scarring without evident xenograft rejection. (Funded by Massachusetts General Hospital and eGenesis.)
Registration is complimentary.
- REGISTER
Speaker
Moderators |
|